Silence Therapeutics plc (SLN)
NASDAQ: SLN · Real-Time Price · USD
6.49
+0.21 (3.34%)
At close: Jul 15, 2025, 4:00 PM
6.38
-0.11 (-1.69%)
After-hours: Jul 15, 2025, 7:22 PM EDT
Silence Therapeutics Market Cap
Silence Therapeutics has a market cap or net worth of $306.52 million as of July 15, 2025. Its market cap has decreased by -64.09% in one year.
Market Cap
306.52M
Enterprise Value
170.05M
1-Year Change
-64.09%
Ranking
Category
Stock Price
$6.49
Market Cap Chart
Since September 8, 2020, Silence Therapeutics's market cap has decreased from $538.37M to $306.52M, a decrease of -43.06%. That is a compound annual growth rate of -10.97%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 14, 2025 | 296.61M | -8.69% |
Dec 31, 2024 | 324.84M | -51.64% |
Dec 29, 2023 | 671.70M | 22.71% |
Dec 30, 2022 | 547.37M | -23.44% |
Dec 31, 2021 | 714.99M | 17.04% |
Dec 31, 2020 | 610.91M | 13.47% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 692.83B |
Johnson & Johnson | 373.35B |
AbbVie | 329.24B |
Novo Nordisk | 299.09B |
UnitedHealth Group | 264.62B |
Novartis AG | 234.87B |
Abbott Laboratories | 228.77B |
AstraZeneca | 217.99B |